What serious adverse reactions happened during this study?
None of the participants who got acalabrutinib and BSC had serious adverse
reactions.
What adverse reactions happened during this study?
The most common adverse reaction was headache.
The table below shows the adverse reactions thought to be related to
acalabrutinib that happened in the participants who got acalabrutinib with BSC
during this study.
Adverse reactions
Acalabrutinib and BSC
Adverse reaction (out of 30 participants)
Headache 6.7% (2)
Bile reflux 3.3% (1)
Decreased levels of platelets, a type of
blood cell that helps form blood clots 3.3% (1)
to stop bleeding
Increased levels of a liver protein
called ALT, which can be a sign of liver 3.3% (1)
damage
Indigestion 3.3% (1)
Mouth ulcer 3.3% (1)
Rash 3.3% (1)
Shingles 3.3% (1)
10 | Clinical Study Results